UPDATED Dec 24, 2025
Discover large cap Belgian Pharmaceuticals & Biotech companies that are on the BEL20. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
UCB | €235.50 | 0.2% | 24.3% | €44.7b | €264.67 | PE33.6x | E17.5% | 0.6% | ||
ARGX | €718.60 | -3.5% | 18.9% | €44.0b | €811.50 | PE33.8x | E26.1% | n/a | ||
TUB | €209.00 | -0.2% | 48.2% | €9.3b | €230.50 | PE100.3x | n/a | 0.5% | ||
HYL | €5.90 | -2.6% | 10.5% | €165.2m | €13.20 | PS19.5x | E79.9% | n/a | ||
ALEMS | €5.12 | -5.2% | -19.2% | €21.7m | n/a | PE18.5x | n/a | n/a | ||
CYAD | €0.18 | -4.2% | -75.1% | €8.1m | n/a | PS43.8x | n/a | n/a | ||
BIOS | €0.0022 | -8.3% | -61.4% | €1.4m | n/a | PE-0.4x | n/a | n/a | ||
OXUR | €0.0074 | 19.4% | -97.2% | €463.2k | n/a | PE0.2x | n/a | n/a |